Kimberly Bertrand, ScD
Assistant Professor
Boston University School of Medicine
Dept of Medicine
Preventive Medicine & Epidemiology

ScD, Harvard School of Public Health
MPH, Boston University School of Public Health



Dr. Bertrand’s research focuses on the epidemiology of breast cancer and non-Hodgkin lymphoma, with an emphasis on understanding environmental, nutritional and lifestyle factors that may influence cancer risk. She recently joined the Black Women’s Health Study (BWHS), a prospective cohort study of over 59,000 African American women begun in 1995. She is also an investigator on a large pooling project of four epidemiologic studies, including the BWHS, to study genetic and nongenetic risk factors for breast cancer subtypes in African American women. Dr. Bertrand is actively involved in several epidemiologic research projects to study risk factors for high mammographic density, a strong independent predictor of breast cancer, and the role mammographic density and other risk factors may play in tumor aggressiveness. In addition, she has developed a special interest in understanding how exposures during early life, including young adulthood, adolescence, childhood, and the perinatal period, may impact cancer risk.

Epidemiologist
Boston University School of Medicine
Slone Epidemiology Center




RiRisk factors for molecular subtypes of NHL - a prospective evaluation
08/01/2016 - 07/31/2021 (PI)
City of Hope NIH NCI
5R01CA202712-02

Mammographic density and breast cancer risk in African American women
06/16/2017 - 05/31/2021 (PI)
NIH/National Cancer Institute
5R01CA214542-02




Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Epstein MM, Rosner B, Breen EC, Batista JL, Giovannucci EL, Magpantay L, Aster JC, Rodig SJ, Bertrand KA, Laden F, Martínez-Maza O, Birmann BM. Pre-diagnosis plasma immune markers and risk of non-Hodgkin lymphoma in two prospective cohort studies. Haematologica. 2018 Jun 21. PMID: 29930163.
     
  2. Schoemaker MJ, Nichols HB, Wright LB, Brook MN, Jones ME, O'Brien KM, Adami HO, Baglietto L, Bernstein L, Bertrand KA, Boutron-Ruault MC, Braaten T, Chen Y, Connor AE, Dorronsoro M, Dossus L, Eliassen AH, Giles GG, Hankinson SE, Kaaks R, Key TJ, Kirsh VA, Kitahara CM, Koh WP, Larsson SC, Linet MS, Ma H, Masala G, Merritt MA, Milne RL, Overvad K, Ozasa K, Palmer JR, Peeters PH, Riboli E, Rohan TE, Sadakane A, Sund M, Tamimi RM, Trichopoulou A, Ursin G, Vatten L, Visvanathan K, Weiderpass E, Willett WC, Wolk A, Yuan JM, Zeleniuch-Jacquotte A, Sandler DP, Swerdlow AJ. Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women. JAMA Oncol. 2018 Jun 21; e181771.View Related Profiles. PMID: 29931120.
     
  3. Samraj AN, Bertrand KA, Luben R, Khedri Z, Yu H, Nguyen D, Gregg CJ, Diaz SL, Sawyer S, Chen X, Eliassen H, Padler-Karavani V, Wu K, Khaw KT, Willett W, Varki A. Polyclonal human antibodies against glycans bearing red meat-derived non-human sialic acid N-glycolylneuraminic acid are stable, reproducible, complex and vary between individuals: Total antibody levels are associated with colorectal cancer risk. PLoS One. 2018; 13(6):e0197464. PMID: 29912879.
     
  4. Chiu YH, Bertrand KA, Zhang S, Laden F, Epstein MM, Rosner BA, Chiuve S, Campos H, Giovannucci EL, Chavarro JE, Birmann BM. A prospective analysis of circulating saturated and monounsaturated fatty acids and risk of non-Hodgkin lymphoma. Int J Cancer. 2018 May 14. PMID: 29756258.
     
  5. Denis GV, Sebastiani P, Bertrand KA, Strissel KJ, Tran AH, Slama J, Medina ND, Andrieu G, Palmer JR. Inflammatory signatures distinguish metabolic health in African American women with obesity. PLoS One. 2018; 13(5):e0196755.View Related Profiles. PMID: 29738558.
     
  6. VoPham T, Bertrand KA, Tamimi RM, Laden F, Hart JE. Ambient PM2.5 air pollution exposure and hepatocellular carcinoma incidence in the United States. Cancer Causes Control. 2018 Jun; 29(6):563-572. PMID: 29696510.
     
  7. Strohsnitter WC, Bertrand KA, Troisi R, Scott CG, Cheville AL, Hoover RN, Palmer JR, Vachon CM. Prenatal diethylstilbestrol exposure and mammographic density. Int J Cancer. 2018 Apr 15.View Related Profiles. PMID: 29658110.
     
  8. VoPham T, Weaver MD, Vetter C, Hart JE, Tamimi RM, Laden F, Bertrand KA. Circadian Misalignment and Hepatocellular Carcinoma Incidence in the United States. Cancer Epidemiol Biomarkers Prev. 2018 Jul; 27(7):719-727. PMID: 29636342.
     
  9. Hart JE, Bertrand KA, DuPre N, James P, Vieira VM, VoPham T, Mittleman MR, Tamimi RM, Laden F. Exposure to hazardous air pollutants and risk of incident breast cancer in the nurses' health study II. Environ Health. 2018 Mar 27; 17(1):28.View Related Profiles. PMID: 29587753.
     
  10. Rice MS, Tamimi RM, Bertrand KA, Scott CG, Jensen MR, Norman AD, Visscher DW, Chen YY, Brandt KR, Couch FJ, Shepherd JA, Fan B, Wu FF, Ma L, Collins LC, Cummings SR, Kerlikowske K, Vachon CM. Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristics. Breast Cancer Res Treat. 2018 Jul; 170(1):129-141. PMID: 29502324.
     
Showing 10 of 83 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 83 publications over 9 distinct years, with a maximum of 20 publications in 2016

YearPublications
20107
20111
20126
20138
20146
20158
201620
201715
201812
Contact for Mentoring:


72 E. Concord St Instructional (L)
Boston MA 02118
Google Map


Bertrand's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department